Literature DB >> 11197599

Interleukin 15: its role in inflammation and immunity.

L P Perera1.   

Abstract

Interleukin 15 (IL-15) is a 14-15 kDa polypeptide that belongs to the 4 alpha-helix-bundle family of cytokines and was originally discovered due to its T cell proliferative activity. It utilizes the signal-transducing beta/gamma polypeptides of the IL-2 receptor complex, thus sharing many biological activities with IL-2, in addition to its high-affinity private receptor subunit IL-15R alpha. Accumulating evidence indicates that the biological relevance of IL-15 may not solely be confined to T lymphocytes, but to a variety of cell populations within the immune system as well as outside the immune system of the host. The expression of both IL-15 and its high-affinity receptor component, IL-15R alpha, are readily demonstrable in a wide variety of tissues and appear to be augmented in response to environmental/stress stimuli and infectious agents. There is increasing evidence to suggest that IL-15 may play an important role in protective immune responses, allograft rejection and the pathogenesis of autoimmune diseases, where mononuclear cell infiltration is a hallmark feature. Herein, the effects of IL-15 on cells associated with host defense, immunity and inflammation are reviewed and support a central role for this cytokine in orchestrating multiple aspects of effector functions in immunity and inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11197599

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  7 in total

1.  Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease.

Authors:  Seiji Yokoyama; Kazuko Takada; Masatomo Hirasawa; Liyanage P Perera; Takachika Hiroi
Journal:  J Clin Immunol       Date:  2011-09-22       Impact factor: 8.317

Review 2.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

3.  Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes.

Authors:  Seiji Yokoyama; Nobumasa Watanabe; Noriko Sato; Pin-Yu Perera; Lyvouch Filkoski; Toshiyuki Tanaka; Masayuki Miyasaka; Thomas A Waldmann; Takachika Hiroi; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-01       Impact factor: 11.205

Review 4.  Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments (Review).

Authors:  Shuyu Liu; Zhenhan Deng; Kang Chen; Shengsheng Jian; Feifei Zhou; Yuan Yang; Zicai Fu; Huanyu Xie; Jianyi Xiong; Weimin Zhu
Journal:  Mol Med Rep       Date:  2022-01-28       Impact factor: 2.952

5.  Host and microbial factors in regulation of T cells in the intestine.

Authors:  Chang H Kim
Journal:  Front Immunol       Date:  2013-06-10       Impact factor: 7.561

Review 6.  The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis.

Authors:  Piotr Wojdasiewicz; Łukasz A Poniatowski; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2014-04-30       Impact factor: 4.711

7.  Interleukin-15 suppresses gastric cancer liver metastases by enhancing natural killer cell activity in a murine model.

Authors:  Wei Wang; Jiejie Jin; Faxiang Dai; Ziwen Long; Xiaowen Liu; Hong Cai; Ye Zhou; Zhong Chen; Hua Huang
Journal:  Oncol Lett       Date:  2018-08-14       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.